These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34816544)

  • 1. Digoxin and beta-blockers in patients with heart failure. Letter regarding the article 'Clinical outcomes with digoxin vs. beta-blocker for heart rate control in permanent atrial fibrillation with heart failure'.
    Čulić V
    Eur J Heart Fail; 2022 Jan; 24(1):239. PubMed ID: 34816544
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to 'Digoxin and beta-blockers in patients with heart failure'. Letter regarding the article 'Clinical outcomes with digoxin vs. beta-blocker for heart rate control in permanent atrial fibrillation with heart failure'.
    Fauchier L; Bisson A; Lip GYH
    Eur J Heart Fail; 2022 Jan; 24(1):239-241. PubMed ID: 34816555
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical outcomes with digoxin vs. beta-blocker for heart rate control in permanent atrial fibrillation with heart failure.
    Bisson A; Ding WY; Bodin A; Lip GYH; Fauchier L
    Eur J Heart Fail; 2021 Sep; 23(9):1563-1565. PubMed ID: 34231295
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
    Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
    Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial.
    Kotecha D; Bunting KV; Gill SK; Mehta S; Stanbury M; Jones JC; Haynes S; Calvert MJ; Deeks JJ; Steeds RP; Strauss VY; Rahimi K; Camm AJ; Griffith M; Lip GYH; Townend JN; Kirchhof P;
    JAMA; 2020 Dec; 324(24):2497-2508. PubMed ID: 33351042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate control in atrial fibrillation: many questions still unanswered.
    Van Gelder IC; Hobbelt AH; Mulder BA; Rienstra M
    Circulation; 2015 Oct; 132(17):1597-9. PubMed ID: 26384161
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-blockers versus digoxin to control ventricular rate during atrial fibrillation.
    Veloso HH; de Paola AA
    J Am Coll Cardiol; 2005 Jun; 45(11):1905-6; author reply 1906-7. PubMed ID: 15936626
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of carvedilol in atrial fibrillation: insights from clinical trials.
    Gheorghiade M; Lukas MA
    Am J Cardiol; 2004 May; 93(9A):53B-7B. PubMed ID: 15144939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutical considerations in associated atrial fibrillation and heart failure.
    Mitu O; Mitu F; Constantin S; Cojocaru E; Leon MM
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):624-30. PubMed ID: 25341275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic control of heart rate in atrial fibrillation.
    Falk RH
    Cardiol Clin; 1996 Nov; 14(4):521-36. PubMed ID: 8950054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Effectiveness of Heart Rate Control Medications for the Treatment of Sepsis-Associated Atrial Fibrillation.
    Bosch NA; Rucci JM; Massaro JM; Winter MR; Quinn EK; Chon KH; McManus DD; Walkey AJ
    Chest; 2021 Apr; 159(4):1452-1459. PubMed ID: 33619010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate-control treatment and mortality in atrial fibrillation.
    Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
    Circulation; 2015 Oct; 132(17):1604-12. PubMed ID: 26384160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate control at least as effective as rhythm control for AF patients.
    Geriatrics; 2002 May; 57(5):63. PubMed ID: 12040594
    [No Abstract]   [Full Text] [Related]  

  • 14. Rate control in atrial fibrillation.
    Van Gelder IC; Rienstra M; Crijns HJ; Olshansky B
    Lancet; 2016 Aug; 388(10046):818-28. PubMed ID: 27560277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dofetilide for atrial fibrillation.
    Ferraro P; Khawari A; Boden WE
    N Engl J Med; 2000 Jan; 342(4):289; author reply 290. PubMed ID: 10660386
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.
    Migaj J; Kałużna-Oleksy M; Nessler J; Opolski G; Crespo-Leiro MG; Maggioni AP; Grajek S; Ponikowski P; Drożdż J; Straburzyńska-Migaj E
    Kardiol Pol; 2018; 76(7):1064-1072. PubMed ID: 29476617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.
    Olshansky B; Rosenfeld LE; Warner AL; Solomon AJ; O'Neill G; Sharma A; Platia E; Feld GK; Akiyama T; Brodsky MA; Greene HL;
    J Am Coll Cardiol; 2004 Apr; 43(7):1201-8. PubMed ID: 15063430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-Blockers and Digoxin in Atrial Fibrillation: Back to the Future.
    Dorian P; Angaran P
    Can J Cardiol; 2023 Nov; 39(11):1594-1597. PubMed ID: 37453646
    [No Abstract]   [Full Text] [Related]  

  • 20. Early outcome of initiating amiodarone for atrial fibrillation in advanced heart failure.
    Weinfeld MS; Drazner MH; Stevenson WG; Stevenson LW
    J Heart Lung Transplant; 2000 Jul; 19(7):638-43. PubMed ID: 10930812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.